Objective:To identify the molecular alterations found in 30 human papillomavirus (HPV) positive (n = 15) and negative (n = 15) vulvar carcinomas (VC) and their associated preinasive lesions (VIN [valvar intraepithelial neoplaisa]) and normal epithelium to determine a common molecular pathogenesis of HPV positive and negative VC.
Methods:Loss of heterozygosity (LOH) at seven 3p chromosomal regions (3p12, 3p14.2, 2p14.3-21.1, 3p21.3, 3p22-24, 3p24.3, 3p25), 13p14 (RB) and 17p13.1 (p53) loci, and TP53 gene mutations in microdissected archival tissues were investigated.
Results:Fourteen of fifteen HPV positive VC had HPN 16DNA sequences. The fractional regional loss index (FRL), an index of total allelic loss at all chromosomal regions analyzed, was greater in the HPV negative VCs than in the HPV positive tumors (FRL = 0.55 versus 0.32; P = .048) and was also greate in the HPV negative high-grade VINs as compared with the HPV positive lesions (0.29 versus 0.02; P = .002). Overall, LOH at any 3p region was frequent (80%) in both groups of cancer and in their associated VIN lesions. Although TP53 gene mutations were present in a minority of VCs (20%), allelic losses at the TP53 locus were ferquently present, especially in HPV negative VCs, as compared with the HPV positive tumors (62% versus 15%; P = .02).
Conclusion:A greater number of molecular alterations are found in HPV negative VCs compred with HPV positive tumors. Allelic losses at 3p are common early events in vulvar carcinogenesis in HPV negative cancer detected at a high rate in the corresponding high-grade precursor lesions (VIN II/III). TP53 gene mutations with associated 17p13.1 LOH are more common in HPV negative cancers.
1. Edwards CL, Tortolero-Luna G, Linares AC, et al. Vulvar intraepithelial neoplasia and vulvar cancer. Obster Gynecol Clin North Am1996;23:295-324.
2.
2. Toki T, Kurman RJ, Park JS, Kessis T, Daniel RW, Shah KV. Probable nonpapillomavirus etiology of sqyamous cells carcinoma of the vulva in older women: A clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol1991;10:107-125.
3.
3. Kurman RJ, Toki T, Schiffman MH, Basaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses [published erratum appears in Am J Surg Pathol 1993;17:536]. Am J Surg Pathol1993;17:133-145.
4.
4. Bloss JD, Liao SY, Wilczynski SP, et al. Clinical and histologic features of vulvar carcinomas analyzed for human papillomavirus status: Evidence that squamous cell carcinoma of the vulva has more than one etiology, Hum Pathol1991;22:711-718.
5.
5. Chen TM, Chen CA, Wu CC, Huang SC, Chang CF, Hsich CY. The genotypes and prognostic significance of human papillomaviruses in cervical cancer. Int. J Cancer1994;57:181-184.
6.
6. Kitchener HC. The role of human papillomavirus in the genesis of cervical cancer. Cancer Treat Res1994;70:29-41.
7.
7. Morrison EA. Natural histroy of cervical infection with human papillomaviruses. Clin Infect Dis1994;18:172-180.
8.
8. Hording U, Junge J, Daugaard S, Lundvall F, Poulsen H, Bock JE, Vulvar squamous cell carcinoma and papillomaviruse: Indications for two different ctiologies. Gynecol Oncol1994;52:241-246.
9.
9. Hietanen SH, Kurvinen K, Syrjanen K, et al. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells. Am J Obstet Gynecol1995;173:1477-1482.
10.
10. Hietanen S, Grenman S, Syrjanen K, et al. Human papillomavirus in vulvar and vaginal carcinoma cell lines [published erratum appears in Br J Cancer 1995 Nov;72(5):1338]. Br J Cancer1995;72:134-139.
11.
11. Lee YY, Wilczynski SP, Chumakov A, Chih D, Koeffler HP, Carcinoma of the vulva: HPV and p53 mutations. Oncogene1994;9:1655-1659.
12.
12. Tervahauta AI, Syrjanen SM, Varynen M, Saastamoinen J, Syrjanen KJ, Expression of p53 protein relate to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions. Anticancer Res1993;13:1107-1111.
13.
13. Pilotti S, D'Amato L, Della Torre G, et al. Papillomavirus, p53 alteration, and primary carcinoma of the vulva. Diagon Mol Pathol1995;4:239-248.
14.
14. Lin MC, Mutter GL, Trivijisilp P, Biynton KA, Sun D, Crum CP. Patterns of allelic loss (LOH) in vulvar squamous carcinomas and adjacent noninvasive epithelia. Am J Pathol1998;152:1313-1318.
15.
15. Pinto AP, Lin MC, Mutter GL, Sun D, Villa LL, Crum CP. Allelic loss in humam papillomavirus-positive and -negative vulvar squamous cell carcinomas. Am J Pathol1999;154:1009-1015.
16.
16. Wistuba, II, Montellano FD, Milechggrub S, et al. Delection of chromosome 3p frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res1997;57:3154-3158.
17.
17. Fishel R. Genomic instability, mutators, and the developemnt of cancer: Is there a role for p53? [editorial: Comment]. J Natl Cancer Inst1996;88:1608-1609.
18.
18. Scurry J, Flowers LC, Vanin K, Nicholas M, Reyes H, Dadzar AF. Human papillomavirus, lichen sclerosis and vulvar squamous cell carcinoma. Int J Gynecol Cancer1998;8L298-306-306.
19.
19. Kurman RJ, Zaino RJ, Norris HJ. Blaustein's pathology of the female genital tract. 4th ed.New York: Springer-Verlag, 1994.
20.
20. Hung J, Kishimoto Y, Sugio K, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA1995;273:1908-1908.
21.
21. Baay MF, Quint WG, Koudstaal J, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol1996;34:745-747.
22.
22. Kishimoto Y, Sugio K, Hung JYm et al. Allele-specific loss in chromosome 9p loci in prebeoplastic lesions accompanying nonsmall-cell lung cancers [see comments]. J Natl Cancer Inst1995;87:1224-1229.
23.
23. Toguchida J, McGee TL, Paterson JC, et al. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics1993;17:535-543.
24.
24. Cawkwell L, Lewis FA, Quirke P. Frequency of allele loss of DCC, p53, RBI, WT1 NF1, NM23 and APC/MCC in colorectal cancer assayed by fluoresecent multiplex polymerase chin raction. Br J Cancer1994;70:813-818.
25.
25. Jones MH, Nakamura Y. Detection of loss of heterozygosity ay the human TP53 locus using a dincleotide repeat polymorphism. Genes Chromosones Cancer1992;55:89-90.
26.
26. Thiberville L, Payne P, Vielkinds J, et al. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res1995;55:5133-5139.
27.
27. Fondon JW, Male GM, Brezinschek RI, et al. Computerized polymorphic marker identification; Experimental validation and a predicted human polymorphism catalog. Proc Natl Acad Sci U S A1998;95:7514-7519.
28.
28. Wistuba II, Behrens C, Milchgrub S, et al. Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. JAMA1998;279:1554-1559.
29.
29. Wistuba, II, Lam S, Behrens C, et al. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst1997;89:1366-1373.
30.
30. Muller CY, O'Boyle J, Fong KM, et al, Abnormalities of the FHIT genomic and cDNAs in himan cervical cancer with HPV subtype correlation. J Natl Cancer Inst1998;90:433-439.
31.
31. Tommansino M, Crawford L. Human paillomavirus E6 and E7: Proteins which deregulate the cell cycle. Bioessays1995;17:509-518.
32.
32. Larson AA, Liao SY, Stanbridge EJ, Cavenee WK, Hampton GM. Genetic alterations accumulate cervical tumorgenesis and indicate a common origin for multifocal lesions. Cancer Res1997;57:417-416.
33.
33. Rader JS, Gerhard DS, O'Sullivan MJ, et al. Cervical intraepithelial neoplasis III shows frequent allelic loss in 3p and 6p. Genes Chromosomes Cancer1998;22:57-65.
